title: Elevation of brachial arterial blood velocity and volumic flow mediated by peripheral beta-adrenoreceptors in patients with borderline hypertension.
abstract: Simultaneous determinations of cardiac output and brachial arterial blood flow were performed in patients with hypertension and high cardiac output in comparison with normal subjects of the same age. Brachial arterial blood flow was measured with a previously described pulsed Doppler apparatus that permitted the noninvasive determination of arterial diameter and blood flow velocity. In patients with borderline hypertension, brachial blood flow was significantly increased (136 +/- 11 vs 72 +/- 8 ml/min; p less than .001). After short-term administration of indomethacin, cardiac output decreased while brachial blood flow remained constant. After short-term administration of a selective beta 1-receptor antagonist (primidolol) and nonselective blocker (propranolol), cardiac output decreased significantly in both cases but the decrease in brachial blood flow was significant only after the administration of the nonselective beta-blocking agent. The study strongly suggested that in patients with borderline hypertension, the increased cardiac output is related to a prostaglandin and beta 1-adrenergic mechanisms whereas the increased brachial blood flow depends mainly on beta 2-adrenergic mechanisms.
authors.forename: J
authors.initials: J
authors.lastname: Levenson
authors.forename: A C
authors.initials: AC
authors.lastname: Simon
authors.forename: M E
authors.initials: ME
authors.lastname: Safar
authors.forename: J D
authors.initials: JD
authors.lastname: Bouthier
authors.forename: G M
authors.initials: GM
authors.lastname: London
mesh_terms: D000328:Adult; D001783:Blood Flow Velocity; D001810:Blood Volume / Q000187:drug effects; D001916:Brachial Artery / Q000503:physiopathology*; D005542:Forearm / Q000098:blood supply; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D011412:Propanolamines / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011943:Receptors, Adrenergic, beta / Q000502:physiology*; D012039:Regional Blood Flow / Q000187:drug effects; D014463:Ultrasonography; D014655:Vascular Resistance / Q000187:drug effects
chemical_list: D011412:Propanolamines; D011943:Receptors, Adrenergic, beta; C025720:primidolol; D011433:Propranolol; D007213:Indomethacin